These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

380 related items for PubMed ID: 29742318

  • 1. A comparative analysis of different automated von Willebrand factor glycoprotein Ib-binding activity assays in well typed von Willebrand disease patients.
    Vangenechten I, Mayger K, Smejkal P, Zapletal O, Michiels JJ, Moore GW, Gadisseur A.
    J Thromb Haemost; 2018 Jul; 16(7):1268-1277. PubMed ID: 29742318
    [Abstract] [Full Text] [Related]

  • 2. Clinically relevant differences between assays for von Willebrand factor activity.
    Boender J, Eikenboom J, van der Bom JG, Meijer K, de Meris J, Fijnvandraat K, Cnossen MH, Laros-van Gorkom BAP, van Heerde WL, Mauser-Bunschoten EP, de Maat MPM, Leebeek FWG, WiN Study Group.
    J Thromb Haemost; 2018 Dec; 16(12):2413-2424. PubMed ID: 30358069
    [Abstract] [Full Text] [Related]

  • 3. Laboratory Testing for von Willebrand Factor Activity by a Glycoprotein Ib-Binding Assay (VWF:GPIbR): HemosIL von Willebrand Factor Ristocetin Cofactor Activity on ACL TOP®.
    Seidizadeh O, Peyvandi F.
    Methods Mol Biol; 2023 Dec; 2663():669-677. PubMed ID: 37204744
    [Abstract] [Full Text] [Related]

  • 4. Gain-of-function GPIb ELISA assay for VWF activity in the Zimmerman Program for the Molecular and Clinical Biology of VWD.
    Flood VH, Gill JC, Morateck PA, Christopherson PA, Friedman KD, Haberichter SL, Hoffmann RG, Montgomery RR.
    Blood; 2011 Feb 10; 117(6):e67-74. PubMed ID: 21148813
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Evaluation of an automated method for measuring von Willebrand factor activity in clinical samples without ristocetin.
    Graf L, Moffat KA, Carlino SA, Chan AK, Iorio A, Giulivi A, Hayward CP.
    Int J Lab Hematol; 2014 Jun 10; 36(3):341-51. PubMed ID: 24750681
    [Abstract] [Full Text] [Related]

  • 7. Laboratory Testing for von Willebrand Factor Activity by Glycoprotein Ib Binding Assays (VWF:GPIb).
    Patzke J, Favaloro EJ.
    Methods Mol Biol; 2017 Jun 10; 1646():453-460. PubMed ID: 28804847
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Towards improved diagnosis of von Willebrand disease: comparative evaluations of several automated von Willebrand factor antigen and activity assays.
    Favaloro EJ, Mohammed S.
    Thromb Res; 2014 Dec 10; 134(6):1292-300. PubMed ID: 25300811
    [Abstract] [Full Text] [Related]

  • 11. Comparison of Von Willebrand factor (VWF) activity VWF:Ac with VWF ristocetin cofactor activity VWF:RCo.
    Geisen U, Zieger B, Nakamura L, Weis A, Heinz J, Michiels JJ, Heilmann C.
    Thromb Res; 2014 Aug 10; 134(2):246-50. PubMed ID: 24891215
    [Abstract] [Full Text] [Related]

  • 12. Performance evaluation and multicentre study of a von Willebrand factor activity assay based on GPIb binding in the absence of ristocetin.
    Patzke J, Budde U, Huber A, Méndez A, Muth H, Obser T, Peerschke E, Wilkens M, Schneppenheim R.
    Blood Coagul Fibrinolysis; 2014 Dec 10; 25(8):860-70. PubMed ID: 25192242
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of a von Willebrand factor three test panel and chemiluminescent-based assay system for identification of, and therapy monitoring in, von Willebrand disease.
    Favaloro EJ, Mohammed S.
    Thromb Res; 2016 May 10; 141():202-11. PubMed ID: 26743192
    [Abstract] [Full Text] [Related]

  • 14. Validation of a new panel of automated chemiluminescence assays for von Willebrand factor antigen and activity in the screening for von Willebrand disease.
    Verfaillie CJ, De Witte E, Devreese KM.
    Int J Lab Hematol; 2013 Oct 10; 35(5):555-65. PubMed ID: 23551532
    [Abstract] [Full Text] [Related]

  • 15. A sensitive ristocetin co-factor activity assay with recombinant glycoprotein Ibalpha for the diagnosis of patients with low von Willebrand factor levels.
    Federici AB, Canciani MT, Forza I, Mannucci PM, Marchese P, Ware J, Ruggeri ZM.
    Haematologica; 2004 Jan 10; 89(1):77-85. PubMed ID: 14754609
    [Abstract] [Full Text] [Related]

  • 16. Correlation between von Willebrand factor antigen, von Willebrand factor ristocetin cofactor activity and factor VIII activity in plasma.
    Lippi G, Franchini M, Salvagno GL, Montagnana M, Poli G, Guidi GC.
    J Thromb Thrombolysis; 2008 Oct 10; 26(2):150-3. PubMed ID: 17786534
    [Abstract] [Full Text] [Related]

  • 17. Von Willebrand factor collagen binding activity in the diagnosis of von Willebrand disease: an alternative to ristocetin co-factor activity?
    Casonato A, Pontara E, Bertomoro A, Sartorello F, Cattini MG, Girolami A.
    Br J Haematol; 2001 Mar 10; 112(3):578-83. PubMed ID: 11260057
    [Abstract] [Full Text] [Related]

  • 18. A rapid assay for ristocetin cofactor activity using an automated coagulometer (ACL 9000).
    Lattuada A, Preda L, Sacchi E, Gallo L, Federici AB, Rossi E.
    Blood Coagul Fibrinolysis; 2004 Sep 10; 15(6):505-11. PubMed ID: 15311161
    [Abstract] [Full Text] [Related]

  • 19. Desmopressin therapy to assist the functional identification and characterisation of von Willebrand disease: differential utility from combining two (VWF:CB and VWF:RCo) von Willebrand factor activity assays?
    Favaloro EJ, Thom J, Patterson D, Just S, Dixon T, Koutts J, Baccala M, Rowell J, Baker R.
    Thromb Res; 2009 Apr 10; 123(6):862-8. PubMed ID: 19064279
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of a fully automated von Willebrand factor assay panel for the diagnosis of von Willebrand disease.
    Stufano F, Baronciani L, Bucciarelli P, Boscarino M, Colpani P, Pagliari MT, Peyvandi F.
    Haemophilia; 2020 Mar 10; 26(2):298-305. PubMed ID: 32107842
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.